Abivax CEO Says Big Pharma Can’t Ignore Its Experimental Drug – Bloomberg.com

Abivax SA’s shares pared gains after France’s finance ministry said it has not been contacted by Eli Lilly & Co. about a possible bid for the French biotech.

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com